In breast cancer, the HER2+ subtype harbors low Notch1 activity and experimental modeling in mouse and cell lines demonstrated the ability of HER2 to negatively regulate Notch1 activity (Osipo et al., 2008). This evidence concerns the gene NOTCH1 and breast cancer.